This chemical is primarily utilized as a chiral ligand in asymmetric catalysis, particularly in transition metal-catalyzed reactions. Its unique structure, featuring a diphenylphosphino group and a sulfinamide moiety, enables it to effectively induce enantioselectivity in various organic transformations. It is commonly employed in asymmetric hydrogenation, carbon-carbon bond-forming reactions, and other stereoselective processes. The anthracenyl group enhances steric and electronic properties, making it suitable for applications in pharmaceutical synthesis, where high enantiomeric purity is critical. Additionally, its robust framework allows for use in challenging catalytic environments, contributing to the development of novel chiral compounds in medicinal chemistry and fine chemical production.